Enhanced dissolution and stability of artemisinin by nano-confinement in ordered mesoporous SBA-15 particles

References

• Ahlneck C, Zografi G. The molecular basis of moisture effects on the physical and chemical stability of drugs in the solid state. Int J Pharm, 1990;62:87–95
   Web of Science ®Google Scholar
• Ali MT, Fule R, Sav A, Amin P. Fabrication of cyclodextrin-templated mesoporous silica for improved dissolution of carbamazepine. Drug Deliv Transl Res, 2013;3:235–42
   Google Scholar
• Ambrogi V, Marmottini F, Pagano C. Amorphous carbamazepine stabilization by the mesoporous silicate SBA-15. Microporous Mesoporous Mater, 2013;177:1–7
   Web of Science ®Google Scholar
• Chan KL, Yuen KH, Takayanagi H, Janadasa S, Peh KK. Polymorphism of artemisinin from Artemisia annua. Phytochemistry, 1997;46:1209–14
   Web of Science ®Google Scholar
• Chen Y, Lin X, Park H, Greever R. Study of artemisinin nanocapsules as anticancer drug delivery systems. Nanomedicine, 2009;5:316–22
   PubMed Web of Science ®Google Scholar
• Ferreira JFS, Zheljazkov VD, Gonzalez JM. Artemisinin concentration and antioxidant capacity of Artemisia annua distillation byproduct. Indust Crops Prod, 2013;41:294–8
   Web of Science ®Google Scholar
• Guo Z, Liu XM, Ma L, Li J, Zhang H, Gao YP, Yuan Y. Effects of particle morphology, pore size and surface coating of mesoporous silica on Naproxen dissolution rate enhancement. Colloids Surf B Biointerfaces, 2013;101:228–35
   PubMed Web of Science ®Google Scholar
• Hailu SA, Bogner RH. Complex effects of drug/silicate ratio, solid-state equivalent pH, and moisture on chemical stability of amorphous quinapril hydrochloride coground with silicates. J Pharm Sci, 2011;100:1503–15
   PubMed Web of Science ®Google Scholar
• Hancock BC, Parks M. What is the true solubility advantage for amorphous pharmaceuticals? Pharm Res, 2000;17:397–404
   PubMed Web of Science ®Google Scholar
• Hancock BC, Zografi G. Characteristics and significance of the amorphous state in pharmaceutical systems. J Pharm Sci, 1997;86:1–12
   PubMed Web of Science ®Google Scholar
• Hu J, Rogers T, Brown J, Young T, Johnston K, Williams III R. Improvement of dissolution rates of poorly water soluble APIs using novel spray freezing into liquid technology. Pharm Res, 2002;19:1278–84
   PubMed Web of Science ®Google Scholar
• Lapenna S, Bilia AR, Morris GA, Nilsson M. Novel artemisinin and curcumin micellar formulations: Drug solubility studies by NMR spectroscopy. J Pharm Sci, 2009;98:3666–75
   PubMed Web of Science ®Google Scholar
• Li J, Zhou B. Biological actions of artemisinin: Insights from medicinal chemistry studies. Molecules, 2010;15:1378–97
   PubMed Web of Science ®Google Scholar
• Li-Hong W, Xin C, Hui X, Li-Li Z, Jing H, Mei-Juan Z, Jie L, Yi L, Jin-Wen L, Wei Z, Gang C. A novel strategy to design sustained-release poorly water-soluble drug mesoporous silica microparticles based on supercritical fluid technique. Int J Pharm, 2013;454:135–42
   PubMedGoogle Scholar
• Limnell T, Heikkilä T, Santos HA, Sistonen S, Hellstén S, Laaksonen T, Peltonen L, Kumar N, Murzin DY, Louhi-Kultanen M, et al. Physicochemical stability of high indomethacin payload ordered mesoporous silica MCM-41 and SBA-15 microparticles. Int J Pharm, 2011;416:242–51
   PubMed Web of Science ®Google Scholar
• Lin AJ, Klayman DL, Hoch JM, Silverton JV, George CF. Thermal rearrangement and decomposition products of artemisinin (qinghaosu). J Org Chem, 1985;50:4504–8
   Web of Science ®Google Scholar
• Liu HZ, Shang KM, Liu WN, Leng DL, Li R, Kong Y, Zhang TH. Improved oral bioavailability of glyburide by a self-nanoemulsifying drug delivery system. J Microencapsul, 2014;31:277–83
   PubMed Web of Science ®Google Scholar
• Liu NQ, Choi YH, Verpoorte R, Van Der Kooy F. Comparative quantitative analysis of artemisinin by chromatography and qNMR. Phytochem Anal, 2010a;21:451–6
   PubMed Web of Science ®Google Scholar
• Liu YH, Sun CS, Hao YR, Jiang TY, Zheng L, Wang SL. Mechanism of dissolution enhancement and bioavailability of poorly water soluble celecoxib by preparing stable amorphous nanoparticles. J Pharm Pharm Sci, 2010b;13:589–606
   PubMed Web of Science ®Google Scholar
• Mellaerts R, Houthoofd K, Elen K, Chen H, Van Speybroeck M, Van Humbeeck J, Augustijns P, Mullens J, Van Den Mooter G, Martens JA. Aging behavior of pharmaceutical formulations of itraconazole on SBA-15 ordered mesoporous silica carrier material. Microporous Mesoporous Mater, 2010;130:154–61
   Web of Science ®Google Scholar
• Nakase I, Lai H, Singh NP, Sasaki T. Anticancer properties of artemisinin derivatives and their targeted delivery by transferrin conjugation. Int J Pharm, 2008;354:28–33
   PubMed Web of Science ®Google Scholar
• Naseem A, Olliff CJ, Martini LG, Lloyd AW. Effects of plasma irradiation on the wettability and dissolution of compacts of griseofulvin. Int J Pharm, 2004;269:443–50
   PubMedGoogle Scholar
• Parvataneni DM, Devraj R, Mangamoori LN. Microparticles-entrapped micelles: A novel delivery system to improve solubility and dissolution rate of poorly water-soluble valsartan. J Microencapsul, 2013;30:805–16
   PubMed Web of Science ®Google Scholar
• Planinšek O, Kovačič B, Vrečer F. Carvedilol dissolution improvement by preparation of solid dispersions with porous silica. Int J Pharm, 2011;406:41–8
   PubMed Web of Science ®Google Scholar
• Qian KK, Bogner RH. Application of mesoporous silicon dioxide and silicate in oral amorphous drug delivery systems. J Pharm Sci, 2012;101:444–63
   PubMed Web of Science ®Google Scholar
• Rahmat N, Abdullah AZ, Mohamed AR. A review: Mesoporous Santa Barbara Amorphous-15, types, synthesis and its applications towards biorefinery production. Am J Appl Sci, 2010;7:1579–86
   Google Scholar
• Rao SS, Song YM, Peddie F, Evans AM. Particle size reduction to the nanometer range: A promising approach to improve buccal absorption of poorly water-soluble drugs. Int J Nanomedicine, 2011;6:1245–51
   PubMed Web of Science ®Google Scholar
• Rengarajan GT, Enke D, Steinhart M, Beiner M. Stabilization of the amorphous state of pharmaceuticals in nanopores. J Mater Chem, 2008;18:2537–9
   Web of Science ®Google Scholar
• Sahoo NG, Kakran M, Li L, Judeh Z. Fabrication of composite microparticles of artemisinin for dissolution enhancement. Powder Tech, 2010;203:277–87
   Web of Science ®Google Scholar
• Sahoo NG, Kakran M, Li L, Judeh Z, Müller RH. Dissolution enhancement of a poorly water-soluble antimalarial drug by means of a modified multi-fluid nozzle pilot spray drier. Mater Sci Eng C, 2011;31:391–9
   Web of Science ®Google Scholar
• Santos HA, Riikonen J, Salonen J, Mäkilä E, Heikkilä T, Laaksonen T, Peltonen L, Lehto V-P, Hirvonen J. In vitro cytotoxicity of porous silicon microparticles: Effect of the particle concentration, surface chemistry and size. Acta Biomater, 2010;6:2721–31
   PubMed Web of Science ®Google Scholar
• Shahzad Y, Shah SNH, Ansari MT, Riaz R, Safdar A, Hussain T, Malik M. Effects of drug-polymer dispersions on solubility and in vitro diffusion of artemisinin across a polydimethylsiloxane membrane. Chin Sci Bull, 2012;57:1685–92
   Web of Science ®Google Scholar
• Shalaev EY, Zografi G. How does residual water affect the solid-state degradation of drugs in the amorphous state? J Pharm Sci, 1996;85:1137–41
   PubMed Web of Science ®Google Scholar
• Shen SC, Ng WK, Chia L, Dong YC, Tan RBH. Stabilized amorphous state of ibuprofen by co-spray drying with mesoporous SBA-15 to enhance dissolution properties. J Pharm Sci, 2009;99:1997–2007
   Web of Science ®Google Scholar
• Shen SC, Ng WK, Chia L, Hu J, Tan RBH. Physical state and dissolution of ibuprofen formulated by co-spray drying with mesoporous silica: Effect of pore and particle size. Int J Pharm, 2011;410:188–95
   PubMed Web of Science ®Google Scholar
• Shiraki K, Takata N, Takano R, Hayashi Y, Terada K. Dissolution improvement and the mechanism of the improvement from cocrystallization of poorly water-soluble compounds. Pharm Res, 2008;25:2581–92
   PubMed Web of Science ®Google Scholar
• Sliwinska-Bartkowiak M, Dudziak G, Gras R, Sikorski R, Radhakrishnan R, Gubbins KE. Freezing behavior in porous glasses and MCM-41. Colloids Surf A Physicochem Eng Asp, 2001;187–188:523–9
   Web of Science ®Google Scholar
• Stringham RW, Lynam KG, Mrozinski P, Kilby G, Pelczer I, Kraml C. High performance liquid chromatographic evaluation of artemisinin, raw material in the synthesis of artesunate and artemether. J Chromatogr A, 2009;1216:8918–25
   PubMed Web of Science ®Google Scholar
• Titulaer HAC, Zuidema J, Kager PA, Wetsteyn JCFM, Lugt CB, Merkus FWHM. The pharmacokinetics of artemisinin after oral, intramuscular and rectal administration to volunteers. J Pharm Pharmacol, 1990;42:810–13
   PubMed Web of Science ®Google Scholar
• Van Den Mooter G. The use of amorphous solid dispersions: A formulation strategy to overcome poor solubility and dissolution rate. Drug Discov Today: Technol, 2012;9:e79–85
   Google Scholar
• Van Speybroeck M, Barillaro V, Thi TD, Mellaerts R, Martens J, Van Humbeeck J, Vermant J, Annaert P, Van Den Mooter G, Augustijns P. Ordered mesoporous silica material SBA-15: A broad-spectrum formulation platform for poorly soluble drugs. J Pharm Sci, 2009;98:2648–58
   PubMed Web of Science ®Google Scholar
• Van Speybroeck M, Mellaerts R, Mols R, Thi TD, Martens JA, Van Humbeeck J, Annaert P, Van Den Mooter G, Augustijns P. Enhanced absorption of the poorly soluble drug fenofibrate by tuning its release rate from ordered mesoporous silica. Eur J Pharm Sci, 2010a;41:623–30
   PubMed Web of Science ®Google Scholar
• Van Speybroeck M, Mols R, Mellaerts R, Thi TD, Martens JA, Humbeeck JV, Annaert P, Mooter GVD, Augustijns P. Combined use of ordered mesoporous silica and precipitation inhibitors for improved oral absorption of the poorly soluble weak base itraconazole. Eur J Pharm Biopharm, 2010b;75:354–65
   PubMed Web of Science ®Google Scholar
• Wang Y, Zhao Q, Hu Y, Sun L, Bai L, Jiang T, Wang S. Ordered nanoporous silica as carriers for improved delivery of water insoluble drugs: a comparative study between three dimensional and two dimensional macroporous silica. Int J Nanomedicine, 2013;8:4015–31
   PubMed Web of Science ®Google Scholar
• Wu C, Wang Z, Chen B, Quan G, Li F, Wu Q, Dian L, Dong Y. Increasing the oral bioavailability of poorly water-soluble carbamazepine using immediate-release pellets supported on SBA-15 mesoporous silica. Int J Nanomedicine, 2012;7:5807–18
   PubMed Web of Science ®Google Scholar
• Xu W, Riikonen J, Lehto VP. Mesoporous systems for poorly soluble drugs. Int J Pharm, 2013;453:181–97
   PubMed Web of Science ®Google Scholar
• Yu H, Zhao X, Zu Y, Zhang X, Zu B, Zhang X. Preparation and characterization of micronized artemisinin via a rapid expansion of supercritical solutions (RESS) method. Int J Mol Sci, 2012;13:5060–73
   PubMed Web of Science ®Google Scholar
• Zhang Y, Zhang J, Jiang T, Wang S. Inclusion of the poorly water-soluble drugs simvastatin in mesocellular foam nanoparticles: Drug loading and release properties. Int J Pharm, 2011;410:118–24
   PubMed Web of Science ®Google Scholar
• Zhang Y, Zhi Z, Jiang T, Zhang J, Wang Z, Wang S. Spherical mesoporous silica nanoparticles for loading and release of the poorly water-soluble drug telmisartan. J Control Release, 2010;145:257–63
   PubMed Web of Science ®Google Scholar
• Zhao P, Jiang H, Jiang T, Zhi Z, Wu C, Sun C, Zhang J, Wang S. Inclusion of celecoxib into fibrous ordered mesoporous carbon for enhanced oral bioavailability and reduced gastric irritancy. Eur J Pharm Sci, 2012;45:639–47
   PubMed Web of Science ®Google Scholar